Ilyang Pharmaceutical Co.,Ltd (007570.KS) KSC

8,320.00

-210(-2.46%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap254.88B
Enterprise Value358.02B
P/E Ratio6.95
PEG Ratio0.08
Price/Sales Ratio0.54
Price/Book Ratio0.55
Enterprise/Revenue0.82
Enterprise/EBITDA89.59

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin-0.02

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue272.24B
Revenue/Share16,337.39
Gross Profit116.35B
EBITDA13.31B
Net Income6.9B
Diluted EPS375.42

Balance Sheet

Total Cash38.79B
Total Cash/Share2,301.43
Total Debt112.65B
Total Debt/Equity0.44
Current Ratio0.96
Book Value Per Share15,281.21

Price History

52-Week Change-35.45
52-Week High16,240
52-Week Low8,100
Moving Average 50 Days11,206.4
Moving Average 200 Days12,557.4

Statistics

Average Volume89,378
Shares Outstanding17.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate155
Trailing Annual Dividend Yield1.86
Payout Ratio0.14
Last Split Factor131:125
Last Split DateMarch 04, 2011